First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - HEMO BIOSCIENCE LTD

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: HEMO BIOSCIENCE LTD, NI646797: COMPANIES HOUSE DEFAULT ADDRESS, 2nd Floor The Linenhall 32-38 Linenhall Street, Belfast, BT2 8BG. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 July 2021. The company was incorporated on 6 July 2017.

The accounts next due date is 30 April 2023. There are no mortgages.

The above was based on public record information as at 1 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: NI646797
Date Incorporated: 6 July 2017
Date Latest Accounts: 31 July 2021
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: NI646797
Annual Return: Unknown
Registered Office: NI646797: COMPANIES HOUSE DEFAULT ADDRESS, 2nd Floor The Linenhall 32-38 Linenhall Street, Belfast, BT2 8BG
SIC Code and Operations: 10890,20420,46450,56290
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

HEMO BIOSCIENCE LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 11 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
10965275 HEMO COSMETICS LTD Dissolved
03789417 HEMO DISTRIBUTION LIMITED Active
10397618 HEMO FINANS LIMITED Active - Proposal to Strike off
12180493 HEMO HEALTH LTD Dissolved
10397639 HEMO INVESTMENT LIMITED Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd